Harlan Waksal

ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.

Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA.

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.

Montclair Art Museum is an institution that showcases a significant collection of George Inness' artworks, as well as other exhibitions such as Woolpunk®: Sunflowers & Graffiti'd Sky in the Garden State, Transformed: Objects Reimagined by American Artists, and New Acquisitions: Jeremy Dennis. The non-profit company is based in Montclair, NJ. The museum also offers family programs and membership opportunities.

American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY.

Part of Neptune Wellness Solutions, Inc., NeuroBioPharm, Inc. is a Canadian company that engages in the research and development of novel proprietary active pharmaceutical ingredients for cognitive and neurological conditions. The private company is based in Laval, Canada. NeuroBioPharm was acquired by Neptune Wellness Solutions, Inc. on February 20, 2015 for $0.22 million.